Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2011, Article ID 230953, 7 pages
http://dx.doi.org/10.1155/2011/230953
Research Article

HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City

1Department of General Internal Medicine, Alpert School of Medicine of Brown University, 593 Eddy St., Providence, RI 02909, USA
2Division of Infectious Diseases, Alpert School of Medicine of Brown University, 164 Summit Avenue Rise Building 148, Providence, RI 02906, USA
3Médicins du Monde, Ho Chi Minh City, Vietnam
4Management Sciences for Health/Supply Chain Management System (MSH/SCMS), 25 Bui Thi Xuan, Hanoi, Vietnam

Received 15 May 2010; Accepted 15 December 2010

Academic Editor: Joep Lange

Copyright © 2011 T. Tony Trinh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Socialist Republic of Vietnam: second country report on following up the implementation to the declaration of commitment on HIV/AIDS January 2006–December 2007,” Hanoi, 2008, http://www.unaids.org.vn/sitee/upload/publications/ungass_en.pdf.
  2. 2009, http://www.unaids.org.vn/sitee/index.php?option=com_content&task=blogsection&id=4&Itemid=26.
  3. WHO, UNAIDS, UNICEF, “Towards universal access: scaling up priority HIV/AIDS interventions in the health sector,” Tech. Rep., June 2008, http://www.who.int/hiv/pub/towards_universal_access_report_2008.pdf. View at Google Scholar
  4. WHO, UNAIDS, UNICEF, “Towards universal access: scaling up priority HIV/AIDS interventions in the health sector,” Tech. Rep., September 2009, http://www.who.int/hiv/pub/tuapr_2009_en.pdf. View at Google Scholar
  5. F. Dabis, E. Balestre, P. Braitstein et al., “Cohort profile: antiretroviral therapy in lower income countries (ART-LINC): international collaboration of treatment cohorts,” International Journal of Epidemiology, vol. 34, no. 5, pp. 979–986, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Braitstein, M. W. Brinkhof, F. Dabis et al., “Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries,” The Lancet, vol. 367, no. 9513, pp. 817–824, 2006. View at Publisher · View at Google Scholar
  7. M. R. Jordan, H. La, H. D. Nguyen et al., “Correlates of HIV-1 viral suppression in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam,” International Journal of STD and AIDS, vol. 20, no. 6, pp. 418–422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. World Health Organization, “Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access,” World Health Organization, Geneva, Switzerland, 2006.
  9. C. Cohen, “Low-level viremia in HIV-1 infection: consequences and implications for switching to a new regimen,” HIV Clinical Trials, vol. 10, no. 2, pp. 116–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. World Health Organization, “Case Definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children,” World Health Organization, Geneva, Switzerland, 2006.
  11. J. A. Bartlett, M. J. Fath, R. DeMasi et al., “An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults,” AIDS, vol. 20, no. 16, pp. 2051–2064, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. L. A. Spacek, H. M. Shihab, M. R. Kamya et al., “Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda,” Clinical Infectious Diseases, vol. 42, no. 2, pp. 252–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Ferradini, A. Jeannin, L. Pinoges et al., “Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment,” The Lancet, vol. 367, no. 9519, pp. 1335–1342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Purkayastha, F. Wasi, and J. Shuter, “Factors associated with sustained virologic suppression in patients receiving antiretroviral therapy in an urban HIV care clinic,” AIDS Patient Care and STDs, vol. 19, no. 12, pp. 785–793, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Chander, S. Himelhoch, J. A. Fleishman et al., “HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use,” AIDS Care, vol. 21, no. 5, pp. 655–663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Palepu, M. Tyndall, B. Yip, M. V. O'Shaughnessy, R. S. Hogg, and J. S. G. Montaner, “Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use,” Journal of Acquired Immune Deficiency Syndromes, vol. 32, no. 5, pp. 522–526, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Wood, T. Kerr, M. W. Tyndall, and J. S. Montaner, “A review of barriers and facilitators of HIV treatment among injection drug users,” AIDS, vol. 22, no. 11, pp. 1247–1256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. B. M. Mathers, L. Degenhardt, B. Phillips et al., “Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review,” The Lancet, vol. 372, no. 9651, pp. 1733–1745, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Ma, D. Zhao, L. Yu et al., “Predictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in China,” Clinical Infectious Diseases, vol. 50, no. 2, pp. 264–271, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. T. A. Nguyen, P. Oosterhoff, A. Hardon, H. N. Tran, R. A. Coutinho, and P. Wright, “A hidden HIV epidemic among women in Vietnam,” BMC Public Health, vol. 8, article 37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Do and H. Guend, “HIV-Related Stigma and HIV: Testing: A Cross-Country Comparison in Vietnam, Tanzania, and Cote dIvoire,” http://iussp2009.princeton.edu/download.aspx?submissionId=92324.
  22. T. K. Hong, M. J. Dibley, and T. Tuan, “Factors affecting utilization of health care services by mothers of children ill with diarrhea in rural Vietnam,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 34, no. 1, pp. 187–198, 2003. View at Google Scholar · View at Scopus
  23. D. V. Duong, C. W. Binns, and A. H. Lee, “Utilization of delivery services at the primary health care level in rural Vietnam,” Social Science and Medicine, vol. 59, no. 12, pp. 2585–2595, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Lynen, S. An, O. Koole et al., “An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia,” Journal of Acquired Immune Deficiency Syndromes, vol. 52, no. 1, pp. 40–48, 2009. View at Publisher · View at Google Scholar
  25. D. Meya, L. A. Spacek, H. Tibenderana et al., “Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria,” Journal of the International AIDS Society, vol. 12, no. 1, p. 3, 2009. View at Google Scholar
  26. R. Kantor, L. Diero, A. Delong et al., “Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings,” Clinical Infectious Diseases, vol. 49, no. 3, pp. 454–462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. D. M. Moore, J. Mermin, A. Awor, B. Yip, R. S. Hogg, and J. S. G. Montaner, “Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings,” Journal of Acquired Immune Deficiency Syndromes, vol. 43, no. 4, pp. 436–439, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. G. P. Bisson, R. Gross, J. B. Strom et al., “Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy,” AIDS, vol. 20, no. 12, pp. 1613–1619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Mee, K. L. Fielding, S. Charalambous, G. J. Churchyard, and A. D. Grant, “Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa,” AIDS, vol. 22, no. 15, pp. 1971–1977, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. J. G. Van Oosterhout, L. Brown, R. Weigel et al., “Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria,” Tropical Medicine and International Health, vol. 14, no. 8, pp. 856–861, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Calmy, N. Ford, B. Hirschel et al., “HIV viral load monitoring in resource-limited regions: optional or necessary?” Clinical Infectious Diseases, vol. 44, no. 1, pp. 128–134, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. P. K. Lee, T. L. Kieffer, R. F. Siliciano, and R. E. Nettles, “HIV-1 viral load blips are of limited clinical significance,” Journal of Antimicrobial Chemotherapy, vol. 57, no. 5, pp. 803–805, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Van Sighem, S. Shang, P. Reiss, L. Gras, M. van der Ende, and F. Kroon, “Immunologic, virologic, and clinical consequences of episodes of transient viremia during suppressive combination antiretroviral therapy,” Journal of Acquired Immune Deficiency Syndromes, vol. 48, pp. 104–108, 2008. View at Google Scholar
  34. C. Orrell, G. Harling, S. E. Lawn, R. Kaplan, M. McNally, and L. G. Bekker, “Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited,” Antivir Ther., vol. 12, pp. 83–88, 2007. View at Google Scholar